News
FDA approves new treatment for highly drug-resistant forms of tuberculosis
Pretomanid, developed by the non-profit TB Alliance, has received U.S. approval in combination regimen with bedaquiline and linezolid for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB
Praj signs technology cooperation agreement with Brazil’s Dedini
Praj’s scope includes technology license engineering and supply of critical equipment, whereas Dedini bears responsibility for manufacturing equipment, site supervision, customer assistance and logistics.
